Your browser is no longer supported. Please, upgrade your browser.
PRGO Perrigo Company plc monthly Stock Chart
PRGO [NYSE]
Perrigo Company plc
IndexS&P 500 P/E- EPS (ttm)-10.47 Insider Own0.47% Shs Outstand143.37M Perf Week-3.82%
Market Cap9.77B Forward P/E12.91 EPS next Y5.28 Insider Trans-0.83% Shs Float137.24M Perf Month-18.77%
Income-1502.50M PEG- EPS next Q1.77 Inst Own76.30% Short Float5.03% Perf Quarter-19.37%
Sales5.64B P/S1.73 EPS this Y-95.80% Inst Trans2.45% Short Ratio3.39 Perf Half Y-26.97%
Book/sh60.52 P/B1.13 EPS next Y-25.60% ROA- Target Price83.75 Perf Year-47.30%
Cash/sh- P/C- EPS next 5Y1.68% ROE- 52W Range67.08 - 132.62 Perf YTD-17.93%
Dividend0.64 P/FCF- EPS past 5Y-59.80% ROI0.60% 52W High-48.51% Beta0.68
Dividend %0.94% Quick Ratio1.10 Sales past 5Y0.10% Gross Margin38.20% 52W Low1.79% ATR2.00
Employees13242 Current Ratio1.70 Sales Q/Q0.80% Oper. Margin- RSI (14)34.10 Volatility2.17% 3.08%
OptionableYes Debt/Eq0.68 EPS Q/Q- Profit Margin- Rel Volume0.36 Prev Close68.16
ShortableYes LT Debt/Eq0.65 EarningsFeb 27 AMC Payout- Avg Volume2.04M Price68.28
Recom2.70 SMA20-5.44% SMA50-9.83% SMA200-20.79% Volume696,209 Change0.18%
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Feb-28-17Reiterated Canaccord Genuity Buy $100 → $97
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Aug-11-16Reiterated Barclays Overweight $120 → $110
Jul-22-16Upgrade Deutsche Bank Hold → Buy $115
Jun-20-16Downgrade Argus Buy → Hold
Apr-26-16Reiterated RBC Capital Mkts Sector Perform $140 → $109
Apr-26-16Reiterated Barclays Overweight $180 → $120
Apr-25-16Downgrade Wells Fargo Outperform → Market Perform
Apr-25-16Downgrade BofA/Merrill Buy → Underperform
Feb-22-16Downgrade Goldman Neutral → Sell
Feb-19-16Initiated Wells Fargo Outperform
Feb-19-16Downgrade B. Riley & Co. Buy → Neutral $239 → $146
Jan-21-16Initiated Barclays Overweight $180
Dec-10-15Upgrade Argus Hold → Buy $170
Dec-03-15Initiated Morgan Stanley Equal-Weight
Mar-23-17 02:31PM  Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members
Mar-20-17 01:11PM  Moody's: Perrigo Filing Delay a "Credit Negative" at The Wall Street Journal
10:22AM  Perrigo Company plc -- Moody's: Perrigo's delayed 10-K filing is credit negative at Moody's
Mar-17-17 04:20PM  PERRIGO CO PLC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tr
Mar-16-17 04:14PM  PERRIGO CO PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligat
04:01PM  Perrigo Provides Update On 2016 Form 10-K Filing PR Newswire
Mar-13-17 04:36PM  Stock market holds its ground as Fed rate decision looms at MarketWatch
Mar-09-17 06:02PM  Perrigo Launches First to Market OTC Equivalent of Rogaine
05:47PM  RPI Finance Trust -- Moody's confirms RPI Finance Trust at Baa2; negative outlook at Moody's
Mar-08-17 08:35AM  Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine® Foam PR Newswire
Mar-07-17 04:03PM  Perrigo Provides 2016 Form 10-K Update PR Newswire
12:38PM  Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan
Mar-06-17 11:49AM  Perrigo Company PLC (PRGO) Becomes The Latest Pharma Investigated Over Price Fixing at Insider Monkey
Mar-03-17 10:25AM  Perrigo Joins Firms With Generic Drugs Under U.S. Glare
06:00AM  Mylan's Governance May Be the Root of Its Problems
Mar-02-17 01:15PM  Perrigo Company PLC (PRGO) Drug Gets FDA Approval at Insider Monkey
Mar-01-17 03:49PM  Perrigo Company PLC (PRGO) Sells Rights To Tysabri at Insider Monkey
12:24PM  Five Companies to Benefit from Activist Starboard Values Involvement in 2017 at Insider Monkey
10:36AM  Pawar Law Group Announces Investigation of Securities Claims Against Perrigo Company plc - PRGO Accesswire
10:13AM  EpiPen maker Mylan forecasts strong 2017; shares jump
08:55AM  Perrigo Announces FDA Final Approval For The Generic Version Of Axiron® Topical Solution, 30 mg/1.5 mL PR Newswire
08:44AM  Why Perrigo Company plc Stock Crashed on Tuesday at Motley Fool
Feb-28-17 08:36PM  [$$] Overheard at The Wall Street Journal -11.70%
07:03PM  Perrigo Company plc -- Moody's: Perrigo Company plc - $2.2 Billion Cash Proceeds From Sale of Tysabri Royalty is Credit Positive at Moody's
04:47PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Perrigo Company plc Business Wire
04:40PM  Dow snaps win streak as investors await Trump speech at MarketWatch
04:13PM  Kite, Ionis Outplay Med Sector As Perrigo, Tenet, Valeant Dive
02:14PM  Two biotechs taking it on the chin
02:13PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Perrigo Company plc (PRGO) PR Newswire
01:23PM  Perrigo Stock Slump Highlights Dubious Milestone at The Wall Street Journal
12:55PM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Perrigo Company plc PRGO Business Wire
11:13AM  RPI Finance Trust -- Moody's reviews RPI Finance Trust for downgrade at Moody's
10:12AM  Big Money Still Long Valeant
09:43AM  Faber Report: Papa don't preach
09:24AM  Perrigo to Sell Tysabri Royalties; Issues Tepid 2017 View
09:09AM  Morning Movers: Target Tanks, Perrigo Plunges, Tenet Tumbles at Barrons.com
09:04AM  US STOCKS-Wall St to open flat as investors await Trump's speech
08:20AM  PERRIGO CO PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events
07:41AM  Early movers: TGT, VRX, AZO, PCLN, PRGO, ETFC & more at CNBC
07:37AM  US STOCKS-Futures flat ahead of Trump's address to Congress
Feb-27-17 09:40PM  [$$] Perrigo to Sell Multiple-Sclerosis Drug Royalties at The Wall Street Journal
09:22PM  After Starboard Agitation, Perrigo Sells MS Drug Royalties for Up to $2.85B
06:21PM  Perrigo sells Tysabri royalty stream, delays annual report
05:51PM  After0hours buzz: PCLN, FTR, PRGO & more at CNBC
05:20PM  Perrigo CFO resigns, effective immediately
04:50PM  Perrigo Shares Plunge On Plans To Sell MS-Drug Royalty Stream
04:42PM  Perrigo shares down 9% after company reports loss, sells drug royalties at MarketWatch
04:09PM  Perrigo to sell Tysabri's royalty stream to Royalty Pharma-sources
04:05PM  Perrigo Company plc Reports Select Preliminary Unaudited Calendar Year 2016 Financial Results And Initial Calendar Year 2017 Guidance PR Newswire
04:03PM  Perrigo Signs Agreement To Divest Tysabri® Royalty Stream For Up To $2.85 Billion PR Newswire
04:01PM  Perrigo Announces Leadership Changes PR Newswire
07:07AM  Q4 2016 Perrigo Company PLC Earnings Release - After Market Close
Feb-25-17 12:25AM  [$$] Home Depot Looks Fit, UPS Looks Squeezed at Barrons.com
Feb-22-17 10:23AM  Coverage initiated on Perrigo by Canaccord Genuity
02:33AM  Israeli supermarket chain Shufersal Q4 profit up
Feb-21-17 11:34AM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
Feb-17-17 08:42AM  Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution PR Newswire
Feb-16-17 08:04AM  Health Care Sector Led the S&P 500s Rally on February 15
Feb-14-17 08:01AM  Perrigo To Release Fourth Quarter And Calendar Year 2016 Results On February 27, 2017 PR Newswire
Feb-13-17 11:46AM  Starboard Value's Jeff Smith Wins Five Perrigo Board Seats at Investopedia
Feb-11-17 01:25AM  [$$] Deckers Outdoor Attracts Activist Investment Firm Marcato at Barrons.com
Feb-10-17 09:28AM  Perrigo Company (PRGO) Q4 Earnings: Disappointment in Store?
Feb-08-17 08:50PM  With Starboard's Smith at Perrigo, Expect M&A, Stock Buybacks at TheStreet
Feb-07-17 04:45PM  [$$] US energy stocks retreat as oil price slips at Financial Times
01:39PM  Board Revised as Perrigo Settles With Activist Investor Starboard
09:54AM  Perrigo adds three directors in deal with activist Starboard
09:43AM  Faber Report: Pharma fumbles
09:06AM  [$$] Starboard Reaches Deal to Shake Up Perrigo Board at The Wall Street Journal
09:05AM  Investor Starboard takes several seats on Perrigo board
08:24AM  Perrigo says it has filed for FDA approval for a generic version of Valeant's acne gel at MarketWatch
08:18AM  Perrigo adds Starboard CEO to its board
08:12AM  Perrigo reaches deal with Starboard to add five independent directors to its board at MarketWatch
08:09AM  Perrigo Confirms Patent Challenge For Generic Version Of Onexton® Gel PR Newswire
08:02AM  Perrigo Announces Agreement With Starboard PR Newswire
Feb-03-17 05:55AM  Hunting down the years 5 hottest M&A targets at MarketWatch
Feb-02-17 12:36PM  Unusual activity: Bulls pile into PRGO & RH
Jan-25-17 12:50PM  Jerome Dodson Comments on Perrigo
12:36PM  Jerome Dodson's Parnassus Fund 4th Quarter Commentary
10:26AM  Perrigo's (PRGO) Generic Version of Topicort Okayed by FDA
Jan-24-17 08:40AM  Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort® Spray, 0.25% PR Newswire
Jan-23-17 09:01AM  Laser-Maker Cynosure Leads Biotech Movers Ahead of Market Open
Jan-18-17 07:47PM  Cramer: The yield on this stock could go down on disappointing Kinder Morgan numbers at CNBC
Jan-17-17 04:05PM  DryShips, Alcobra Sink into Tuesdays 52-Week Low Club
10:00AM  Is Perrigo Company (PRGO) a Great Stock for Value Investors?
Jan-14-17 03:38PM  Perrigo, Ralph Lauren Reach 3-Year Low Prices
Jan-12-17 09:30AM  Biotech and Healthcare Stocks Hit Hard by President Trump's Comments: Latest Reports on Endo International and Perrigo Accesswire
Jan-11-17 05:29PM  Why Perrigo, Novadaq Technologies, and Ethan Allen Interiors Slumped Today at Motley Fool -6.90%
01:59PM  Trump's Comments Slam Drug Stocks at The Wall Street Journal
10:43AM  'The New Valeant'
Jan-10-17 10:53PM  [$$] Valeant Strikes Deals to Shed $2.1 Billion in Assets at The Wall Street Journal
02:06PM  [$$] Valeant Strikes Deals to Shed More Assets at The Wall Street Journal
08:41AM  PERRIGO CO PLC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements
08:27AM  Perrigo Updates Segment Reporting Structure PR Newswire
Jan-07-17 03:03PM  These 9 Allergan Drugs May Now Cost as Much as 9.5% More in 2017
Jan-05-17 11:34AM  Perrigo Co. Plc Value Analysis (NYSE:PRGO) : January 5, 2017
Jan-04-17 08:08AM  Perrigo Co. Plc breached its 50 day moving average in a Bullish Manner : PRGO-US : January 4, 2017
Jan-01-17 05:48PM  Bargain Hunting: The 10 Worst-Performing Dividend Achievers of 2016
Dec-30-16 04:18PM  5 Worst Performers in the S&P 500 in 2016 at The Wall Street Journal
04:00PM  Make Sure Your Portfolio Is Protected From Volatility
Dec-29-16 08:32AM  Citron Research Tweet Pulled NVIDIA Prices Lower on December 28
Perrigo Company plc, together with its subsidiaries, develops, manufactures, markets, and distributes over-the-counter (OTC) consumer goods and pharmaceutical products worldwide. The company operates through Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences, and Other segments. The CHC segment offers OTC products in various categories, including analgesics, cough/cold/allergy/sinus, gastrointestinal, infant nutritional, smoking cessation, animal health, feminine hygiene, diabetes and dermatological care, diagnostic, scar management, and other healthcare products, as well as vitamins, minerals, and dietary supplements (VMS); and contract manufacturing services. It serves retail drug, supermarket, mass merchandise chains, and wholesalers through sales force and industry brokers. The BCH segment provides branded OTC products in the natural health and VMS; cough, cold, flu, and allergy; personal care and derma-therapeutics; lifestyle; pain relief, nasal decongestants, and cold sore management; and anti-parasite areas, as well as offers generic pharmaceutical products. It serves pharmacies, drug, and grocery stores through pharmacy sales force, as well as a network of pharmacists. The Rx segment offers generic and specialty pharmaceutical prescription drugs in various dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, women's health products, oral solid dosage forms, and oral liquid formulations; and ORx products. It serves wholesalers; retail drug, supermarket, and mass merchandise chains; hospitals; and pharmacies. The Specialty Sciences segment offers Tysabri to treat multiple sclerosis. The Other segment offers active pharmaceutical ingredients used by generic and branded pharmaceutical companies. The company was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wesolowski JohnEVP, President RxDec 15Option Exercise82.6132526,848325Dec 19 04:07 PM
Brown Judy LEVP, Business Ops & CFONov 25Sale89.442,097187,55610,007Nov 28 04:29 PM
Parker Geoffrey M.DirectorNov 21Buy88.752,500221,8752,500Nov 21 03:14 PM
KINGMA TODD WExecutive VP, General CounselNov 21Sale88.6875066,51214,560Nov 23 02:30 PM
Brown Judy LEVP, Business Ops & CFOOct 24Sale90.422,092189,15912,104Oct 26 02:44 PM
Farrington ThomasEVP and CIOSep 26Sale96.761,110107,4042,970Sep 28 01:47 PM
Brown Judy LEVP, Business Ops & CFOSep 26Sale96.762,096202,80914,196Sep 28 01:47 PM
KUNKLE GARY K JRDirectorSep 09Option Exercise16.775,81497,50131,501Sep 13 03:01 PM
KUNKLE GARY K JRDirectorSep 09Sale89.955,814522,97425,687Sep 13 03:01 PM
MORRIS HERMAN JRDirectorSep 08Option Exercise16.775,81497,50110,425Sep 09 04:33 PM
MORRIS HERMAN JRDirectorSep 08Sale90.961,07397,5959,352Sep 09 04:33 PM
Brown Judy LEVP, Business Ops & CFOAug 26Sale88.282,095184,94716,292Aug 30 04:38 PM
Weninger PaulEVP, Quality OperationsAug 22Option Exercise91.5218817,2062,296Aug 24 03:54 PM
Brown Judy LEVP, Business Ops & CFOAug 22Option Exercise91.522,877263,30319,717Aug 24 03:53 PM
Farrington ThomasEVP and CIOAug 22Option Exercise91.5269363,4234,299Aug 24 03:53 PM
Quinn GrainneEVP, Chief Medical OfficerAug 22Option Exercise91.522,168198,4153,208Aug 24 03:53 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 22Option Exercise91.521,336122,27111,327Aug 24 03:52 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 22Option Exercise91.5230127,5481,586Aug 24 03:52 PM
HENDRICKSON JOHN TCEOAug 22Option Exercise91.521,536140,5755,401Aug 24 03:52 PM
Kochan SharonEVP, GM InternationalAug 22Option Exercise91.521,336122,27110,088Aug 24 03:51 PM
KINGMA TODD WExecutive VP, General CounselAug 22Option Exercise91.521,536140,57515,796Aug 23 04:58 PM
Brown Judy LEVP, Business Ops & CFOAug 19Option Exercise91.831,692155,37614,121Aug 23 04:58 PM
KINGMA TODD WExecutive VP, General CounselAug 19Option Exercise91.831,692155,37612,012Aug 23 04:58 PM
Kochan SharonEVP, GM InternationalAug 19Option Exercise91.831,01593,2076,898Aug 23 04:57 PM
Needham JeffreyEVP, GM Consumer HealthcareAug 19Option Exercise91.8333831,0397,678Aug 23 04:57 PM
Farrington ThomasEVP and CIOAug 19Option Exercise91.831,692155,3762,886Aug 23 04:57 PM
HENDRICKSON JOHN TCEOAug 19Option Exercise91.831,692155,3761,692Aug 23 04:56 PM
JANDERNOA MICHAEL JDirectorMay 04Option Exercise95.7092488,4278,774May 06 04:23 PM
MORRIS HERMAN JRDirectorMay 04Option Exercise95.7092488,4275,055May 06 04:23 PM
FOUSE JACQUALYN ADirectorMay 04Option Exercise95.7092488,4274,360May 06 04:24 PM
COHEN GARY MDirectorMay 04Option Exercise95.7092488,42713,795May 06 04:24 PM
Yanai ShlomoDirectorMay 04Option Exercise95.7092488,427924May 06 04:22 PM
BRLAS LAURIEDirectorMay 04Option Exercise95.7092488,42710,901May 06 04:22 PM
KUNKLE GARY K JRDirectorMay 04Option Exercise95.7092488,42726,131May 06 04:23 PM
Hoffing Ellen RandiDirectorMay 04Option Exercise95.7092488,4279,528May 06 04:24 PM
Brown Judy LExecutive VP & CFOApr 13Option Exercise113.772,776315,82513,924Apr 14 03:38 PM
Brown Judy LExecutive VP & CFOApr 13Sale126.222,776350,38712,429Apr 14 03:38 PM